INTERIM REPORT
JANUARY 1 - MARCH 31, 2026
Continued high margins and increased acquisition activity
AddLife is starting 2026 with continued high margins. After a strong finish to 2025, sales were somewhat subdued at the beginning of the year, but the quarter ended with good growth and the underlying trends are clearly positive. With a strong balance sheet, the pace of acquisitions has increased and two acquisitions were completed in March and April.
Fredrik Dalborg, President and CEO
FIRST QUARTER
- Net sales decreased by 2 percent to SEK 2,645 million (2,702). Adjusted for operations divested in December 2025, organic growth amounted to 3 percent, acquired growth amounted to 2 percent, and exchange rate effects had a negative impact of 4 percent.
- EBITA decreased by 3 percent to SEK 332 million (343), corresponding to an EBITA margin of 12.5 percent (12.7). Exchange rate effects had a negative impact of 4 percent on EBITA.
- Profit after tax increased by 7 percent to SEK 128 million (120).
- Earnings per share amounted to SEK 1.04 (0.98). For the latest 12‑month period, earnings per share amounted to 4.66 (2.53).
- Cash flow from operating activities amounted to SEK 104 million (240).
- The equity ratio was 44 percent (43).
- Return on working capital (P/WC) amounted to 61 percent (62).
- In March, the acquisition of BioSpectrum Ltd., United Kingdom, was completed. The acquisition is expected to contribute annual net sales of approximately SEK 75 million.
- After the end of the interim period, the acquisition of CoaChrom Diagnostica GmbH, Austria, was completed. The acquisition is expected to contribute annual net sales of approximately SEK 110 million.
| Q1 | Q1 | ∆ | Apr 2025- | Full year | |
| SEKm | 2026 | 2025 | % | Mar 2026 | 2025 |
| Net sales | 2,645 | 2,702 | -2 | 10,385 | 10,442 |
| EBITA | 332 | 343 | -3 | 1,406 | 1,417 |
| EBITA margin, % | 12.5 | 12.7 | 13.5 | 13.6 | |
| Adjusted EBITA | 332 | 343 | -3 | 1,248 | 1,259 |
| Adjusted EBITA margin, % | 12.5 | 12.7 | 12.0 | 12.1 | |
| Profit/loss before taxes | 183 | 172 | 7 | 783 | 772 |
| Profit for the period | 128 | 120 | 7 | 570 | 562 |
| Earnings per share (EPS), before/after dilution, SEK | 1.04 | 0.98 | 6 | 4.66 | 4.59 |
| Cash flow from operating activities | 104 | 240 | -57 | 1,256 | 1,392 |
12.5%
EBITA MARGIN
7%
PROFIT GROWTH
61%
P/WC
2.3
NET DEBT/EBITDA